CSIMarket
 
Rxsight Inc   (RXST)
Other Ticker:  
 
 
Price: $47.1900 $0.99 2.143%
Day's High: $47.32 Week Perf: -6.33 %
Day's Low: $ 45.23 30 Day Perf: -9.41 %
Volume (M): 635 52 Wk High: $ 58.21
Volume (M$): $ 29,956 52 Wk Avg: $31.27
Open: $45.81 52 Wk Low: $15.15



 Market Capitalization (Millions $) 1,683
 Shares Outstanding (Millions) 36
 Employees -
 Revenues (TTM) (Millions $) 75
 Net Income (TTM) (Millions $) -55
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 4

Rxsight Inc
RxSight Inc. is a medical technology company that specializes in developing and manufacturing intraocular lens (IOL) systems for cataract patients. The company has developed an innovative IOL platform called the Light Adjustable Lens (LAL), which allows for postoperative adjustments to the lens power and corrects residual refractive errors. This technology helps patients achieve better visual outcomes after cataract surgery. RxSight Inc. was founded in 1998 and is headquartered in California, United States.


   Company Address: 100 Columbia Aliso Viejo 92656 CA
   Company Phone Number: 521-7830   Stock Exchange / Ticker: NASDAQ RXST
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Stock Market Announcement

RxSight, Inc. Achieves Stellar Financial Performance in 2023 and Shows Promising Outlook for 2024.

Published Sun, Jan 7 2024 3:00 PM UTC



RxSight, Inc., a leading ophthalmic medical device company, has recently revealed their preliminary unaudited financial and operational results for the fourth quarter and full-year 2023. Additionally, the company provided guidance for the upcoming year, projecting a bright future. This article aims to outline the notable facts from the press release and assess the...

Rxsight Inc

Revolutionary Breakthrough by Rxsight Inc: Profits Soar as Revenue Rockets amidst 2023's Third Quarter

Energetic Revenue Growth Propels Rxsight Inc to Impressive Q3 Performance
The stock market is buzzing with excitement as Rxsight Inc, a leading Medical Equipment & Supplies company, reports a stunning revenue advance in its third quarter of 2023. Surpassing all expectations, the company achieved a remarkable 72.263% increase in revenue, reaching an impressive $21.73 million. This outstanding performance has not only helped the company cut its losses to $-0.35 per share but also demonstrates its ability to outpace its sector counterparts.
In comparison to the rest of the Medical Equipment & Supplies sector, which showed a modest 4.89% increase in revenue during the same period, Rxsight Inc has clearly emerged as a frontrunner. This significant revenue growth is a testament to the company's strong financial strategy and its commitment to catering to the evolving needs of its customers.
The positive news doesn't end there. Rxsight Inc's second quarter results showed an 8.574% revenue increase from $20.02 million, with an improved EPS of $-0.40 per share. This steady growth trajectory affirms the company's dedication to consistently delivering positive outcomes.

Rxsight Inc

Rxsight Inc. Records Dramatic Revenue Growth, Curbing Deficit in Q2 2023


Introduction
Rxsight Inc, a prominent player in the Medical Equipment & Supplies industry, has recently reported an impressive growth in revenue for the financial span ending June 30, 2023. The company's revenue rose by an astounding 76.188%, reaching $20.02 million in this period. This surge has considerably reduced its losses as well, with earnings per share (EPS) improving from $-0.61 to $-0.40 compared to the same reporting period last year. Let's delve deeper into this fascinating development within the stock market.
Outperforming Industry Contemporaries
Rxsight Inc has clearly outperformed its industry contemporaries when it comes to top-line growth. While the Medical Equipment & Supplies industry as a whole has shown a healthy 4.21% growth in revenue for the same period, Rxsight Inc's revenue rise of 76.188% is truly remarkable. This highlights the company's ability to gain a competitive edge in the industry and attract more customers.

Rxsight Inc

Rxsight Inc's Q1 2023 Financial Report Reveals Remarkable Revenue Surge

Rxsight Inc's Financial Report Shows Strong Revenue Growth

Rxsight Inc, a medical technology company, has reported strong revenue growth in their most recent fiscal period, according to their financial report.
For the period, the company showed a loss of $-0.42 per share, an improvement from the $-0.64 loss per share reported in the same period the previous year.
Additionally, revenue for the company grew by an impressive 95.583%, reaching $17.49 million from $8.94 million from the same period the previous year.
Sequentially, revenue advanced by 8.708% from $16.09 million.






 

Rxsight Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com